Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery.

Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery. J Biomol Struct Dyn. 2021 09; 39(15):5722-5734.

View in: PubMed